Forcados C, Köksal H, Scherer E, Abrantes R, Dillard P, Duarte HO, Josefsson S, Gomes C, de Montlaur C, Hellesøy HTZ, Dunkel R, Smeland EB, Myklebust JH, Reis CA, McCormack E, Gelebart P, Inderberg EM, Wälchli S (2026)
Reviving low-affinity glycan-targeting CAR with combinatorial design
Cell Rep Med, 103108 (in press)
DOI 10.1016/j.xcrm.2026.103108, PubMed 42849448

Tjärnhage E, Våtsveen TK, Raki M, Nemazee D, Farhan H, Munthe L, Grodeland G (2026)
Repurposing ALK inhibitors as influenza and corona virus antivirals targeting lymphocyte tyrosine kinase (LTK)
Virus Res, 370, 199759
DOI 10.1016/j.virusres.2026.199759, PubMed 42263913

Myklebust JH (2026)
Predicting and reversing T-cell engager resistance
Blood, 147 (23), 2704-2705
DOI 10.1182/blood.2026033471, PubMed 42241044